🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Niranjan Sathianathen Declan Murphy Overwhelming consensus at #AUA2022 that virtual presentations are here to stay! Nice discussion on the responsibility of the presenter to maintain professionalism. Do urology units have a duty to provide AV equipment and training? Kenneth Chen

Declan Murphy presenting initial results of the #Lutectomy trial at the #EAU22 main stage. Neoadjuvant Lu-PSMA is safe, effective and does not affect surgical difficulty. Excited for full study results at #EAU23! More discussion in an upcoming episode of GUcast.org

Jonathan O'Brien Declan Murphy Super thanks to our ProsTIC fellow Jonathan O'Brien ... #LuTectomy wouldn't be possible without the help of you and the entire team. Shoutout to James Buteau Nattakorn Knight Dhiantravan Omar Alghazo

Marc Diocera Kenneth Chen Declan Murphy Nathan Lawrentschuk Daniel Moon Renu Eapen Emma Birch GU Cast | Urology podcast! Australia & New Zealand Urological Nurses Society Peter Mac Cancer Centre In 2014, ROBOCAP pre-prostatectomy education was great. I'm sure your new telehealth program is just as valuable, more accessible to more people, but with less passing physical objects around.

Brian F. Chapin Kevin Ginsburg @chrisfilson_uro That’s a big underestimation. Nice meta-analysis by Chow et al European Urology showed ~74% sensitivity for nodal disease, albeit with alot of study heterogeneity and also all Ga68 which most in US don’t have access to.

Always an absolute pleasure to have the Petermac team Declan Murphy Michael Hofman down for Urofair expounding on latest insights on how PSMA PET is changing PCa management!

Great to see Peter Mac Cancer Centre Alumnus Kenneth Chen as Chair of #UroFair23

Wonderful to join Declan Murphy at #UroFair23 in Singapore. Lot's of great discussion about how to best use PSMA PET and Lutetium-PSMA therapy to improve outcomes for patients with prostate cancer.

A successful Urofair 2023 by Kenneth Chen . Bringing the urology community to another pedestal and we renew friendship and share experiences after the pandemic!

Full attendance Singapore General Hospital Urology Kae Jack Tay Kenneth Chen eejeanlim @sghuro SingHealth

Combination treatment in metastatic #ProstateCancer: Is the bar too high or have we fallen short? Kenneth Chen joins Alicia Morgans, MD, MPH to discuss a Nature Reviews Urology article looking at factors that influence patients' access to effective treatments > bit.ly/3rrihNd

When I was a trainee, I always wonder, why do we have to rely on TURBT to stage a MIBC? Can we possibly biopsy the detrusor muscle during flex cystoscopy? If so, perhaps we can spare TURBT and proceed to radical cystectomy directly in patients with biopsy-proven MIBC? (1/n)

📢 LuTectomy online European Urology📢 ✨ 🔍 Findings: 🔹Effective targeted radiation 🔹Minimal side effects & surgical safety 🔹Potential new chapter in neoadjuvant therapy for HRCaP? 🔗 authors.elsevier.com/c/1h~Xq14kplvA… 🍾Renu Eapen Declan Murphy 💰Movember USA

Amazing 2 days of brainstorming cutting edge #endourology japan Olympus headquarters from the 🌎 over Kenneth Chen Steffi Yuen Damien Bolton The Chinese University of Hong Kong - CUHK Chinnakhet Ketsuwan Get ready to be amazed 👏 Endourological Society #UroSoMe Olympus Urology Europe Olympus Medical Systems EMEA Olympus Medical Americas

Only two weeks until the #IBCG24 Retreat! Looking forward to welcoming top bladder cancer experts, dedicated patient advocates and partners from around the globe to Houston The retreat chaired by Roger Li Patrick Hensley, MD Shilpa Gupta is all about collaboration: together, we’ll

And the 2nd IBCG retreat is off to a great start! #IBCG24 fantastic turnout and looking forward to some great discussions and recommendations.

Most fruitful time spent at #IBCG24! Great discussions on various aspects of BCa care from consolidation of our understanding of IR NMIBC to meaningful trial definitions and endpoints. Fraility assessment over age for neoadjuvant chemo! Kudos to Ashish M. Kamat, MD, MBBS IBCG 👍🏻👏🏻

Timely! Just out from #IBCG23 as we wrap up #IBCG24: Bladder-sparing Therapy for BCG–unresponsive NMIBC: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection authors.elsevier.com/a/1jfA914kplyy… IBCG World Bladder Cancer Patient Coalition Bladder Cancer Advocacy Network

IBCG24 has officially concluded, and what an inspiring event it was! The passion, dedication, and collaboration on display were truly remarkable. A huge thank you to all the participants, especially our patient advocates, whose valuable insights and unwavering commitment to